title: Sexually transmitted infections among incarcerated women: findings from a decade of screening in a Los Angeles County Jail, 2002-2012.
abstract: OBJECTIVE
  We describe and report findings from a screening program to identify sexually transmitted infections (STIs) and HIV among female inmates in Los Angeles County Jail.
  
  
  METHODS
  Chlamydia and gonorrhea screening was offered to entering female inmates. Women were eligible if they were (1) aged 30 years or younger, or (2) pregnant or possibly pregnant, or (3) booked on prostitution or sex-related charges. Voluntary syphilis and HIV testing was offered to all women between 2006 and 2009. This analysis reports on data collected from 2002 through 2012.
  
  
  RESULTS
  A total of 76,207 women participated in the program. Chlamydia prevalence was 11.4% and gonorrhea was 3.1%. Early syphilis was identified in 1.4% (141 of 9733) and the overall prevalence of HIV was 1.1% (83 of 7448). Treatment levels for early syphilis and HIV were high (99% and 100%, respectively), but only 56% of chlamydia and 58% of gonorrhea cases were treated.
  
  
  CONCLUSIONS
  Screening incarcerated women in Los Angeles County revealed a high prevalence of STIs and HIV. These inmates represent a unique opportunity for the identification of STIs and HIV, although strategies to improve chlamydia and gonorrhea treatment rates are needed.
authors.affiliation: Marjan Javanbakht, Laura J. Anderson, and Lisa V. Smith are with Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles. L. V. Smith is also with Office of Health Assessment and Epidemiology, Los Angeles County Department of Public Health, Los Angeles. Melina Boudov, Michael Chien, and Sarah Guerry are with Division of HIV and STD Programs, Los Angeles County Department of Public Health. Mark Malek is with Infection Control and Epidemiology Unit, Medical Services Bureau, Los Angeles County Sheriff's Department, Los Angeles.
authors.forename: Marjan
authors.initials: M
authors.lastname: Javanbakht
authors.forename: Melina
authors.initials: M
authors.lastname: Boudov
authors.forename: Laura J
authors.initials: LJ
authors.lastname: Anderson
authors.forename: Mark
authors.initials: M
authors.lastname: Malek
authors.forename: Lisa V
authors.initials: LV
authors.lastname: Smith
authors.forename: Michael
authors.initials: M
authors.lastname: Chien
authors.forename: Sarah
authors.initials: S
authors.lastname: Guerry
mesh_terms: D000293:Adolescent; D000328:Adult; D002690:Chlamydia Infections / Q000453:epidemiology; D005260:Female; D006069:Gonorrhea / Q000453:epidemiology; D015658:HIV Infections / Q000453:epidemiology; D006801:Humans; D015141:Los Angeles / Q000453:epidemiology; D009025:Morpholines; D011329:Prisoners / Q000706:statistics & numerical data*; D011330:Prisons / Q000706:statistics & numerical data; D012749:Sexually Transmitted Diseases / Q000453:epidemiology*; D013587:Syphilis / Q000453:epidemiology; D055815:Young Adult
chemical_list: D009025:Morpholines; C071738:2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate